RESTORE Act

S 4533 (RESTORE Act) aims to improve access to restorative reproductive medicine for women with conditions like endometriosis, fibroids, and polycystic ovary syndrome. It requires federal reports assessing standard care for infertility and reproductive health conditions, including access to fertility awareness methods and restorative treatments. The bill expands national health surveys to track reproductive health needs, prohibits discrimination against providers who don't use assisted reproductive technology, and directs funding toward training in restorative approaches like NaProTECHNOLOGY. It directly affects women experiencing infertility (15-16% of couples), healthcare providers, and insurance plans covering these services. The law focuses on diagnostic and treatment pathways rather than assisted reproduction, emphasizing evidence-based care for underlying conditions.